A. Crider

发表

Drug Design and Discovery in Alzheimer’s Disease

Kenneth J. Witt, M. Z. Ahmad, Eric A. Owens, 2014 .

Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice.

W. Banks, J. Morley, S. Farr, 2011, European journal of pharmacology.

A comparison of prodrug esters of nipecotic acid

J. Wood, A. Crider, C. Hinko, 1988, Neuropharmacology.

Effects of selected PCB congeners on survival, growth, and reproduction in Daphnia magna

T. Dillon, W. Benson, A. Crider, 1990 .

Nonpeptide somatostatin agonists with sst4 selectivity: synthesis and structure-activity relationships of thioureas.

C. Tang, C. Stidsen, A. Crider, 1998, Journal of medicinal chemistry.

Recent advances in the development of nonpeptide somatostatin receptor ligands.

A. Crider, 2002, Mini reviews in medicinal chemistry.

Somatostatin receptor agonists and antagonists

A. Crider, 2003 .

cis- and trans-2,3,3a,4,5,9b-Hexahydro-1H-benz[e]indoles: synthesis and evaluation of dopamine D2, and D3 receptor binding affinity

M. Scheideler, A. Crider, Debasis Ghosh, 1999 .

Synthesis and anticonvulsant activity of racemic 2-amino-N-substituted succinimide derivatives.

A. Crider, T. M. Kolczynski, D. Miskell, 1981, Journal of pharmaceutical sciences.

Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ₁₋₄₂ trimers.

W. Banks, J. Morley, S. Farr, 2012, European journal of pharmacology.

Synthesis, microbial transformation, and pharmacological evaluation of 4,5-dihydronaphtho[2,1-b]furan-2-ones and related analogues

A. Mayer, A. Crider, A. Foudah, 2013 .

Synthesis and anticancer activity of nitrosourea derivatives of phensuximide.

A. Crider, K. Yates, T. M. Kolczynski, 1980, Journal of medicinal chemistry.

Potential long-acting anticonvulsants. 2. Synthesis and activity of succinimides containing an alkylating group on nitrogen or at the 3 position.

A. Crider, M. Kornet, E. O. Magarian, 1977, Journal of medicinal chemistry.

Potential long-acting anticonvulsants. 1; Synthesis and activity of succinimides containing an alkylating group at the 2 position.

A. Crider, M. Kornet, E. O. Magarian, 1977, Journal of medicinal chemistry.

Synthesis of 2-piperidinecarboxylic acid derivatives as potential anticonvulsants

J. Stables, A. Crider, P. H. Andersen, 1998 .

Nonpeptide Somatostatin Agonists with sst4 Selectivity: Synthesis and Structure—Activity Relationships of Thioureas.

C. Stidsen, A. Crider, M. Ankersen, 1999 .

Synthesis of nitrosourea derivatives of pyridine and piperidine as potential anticancer agents.

A. Crider, H. Floss, J. Cassady, 1980, Journal of medicinal chemistry.

Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity, and gastrointestinal toxicity.

A. Crider, R. Gokhale, R. Dick, 1992, Journal of pharmaceutical sciences.

Convenient synthesis of 6-nor-9,10-dihydrolysergic acid methyl ester.

A. Crider, K. Bachmann, A. Rawat, 1981, Journal of Pharmacy and Science.

Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors.

J. Clemens, A. Crider, J. M. Robinson, 1977, Journal of medicinal chemistry.

cis-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles: synthesis and in vitro binding affinity at dopamine D1 and D2 receptors.

A. Crider, P. H. Andersen, R. Dick, 1993, Journal of pharmaceutical sciences.

Synthesis of cis-4-methyl-3-phenylpyrrolidines as potential dopaminergic agonists

W. Leader, A. Crider, K. Tschappat, 1988 .

Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.

S. Fahn, A. Crider, M. Hassan, 1984, Journal of pharmaceutical sciences.

CONVENIENT SYNTHESIS OF 6‐NOR‐9,10‐DIHYDROLYSERGIC ACID METHYL ESTER

A. Crider, K. Bachmann, A. Rawat, 1982 .

gamma-Aminobutyric acid uptake inhibition and anticonvulsant activity of nipecotic acid esters.

K. Seibert, J. Wood, A. Crider, 1984, Journal of pharmaceutical sciences.

Anticonvulsant Activity of Novel Derivatives of 2- and 3-Piperidinecarboxylic Acid in Mice and Rats

A. El-Assadi, H. Bin, A. Crider, 1996, Neuropharmacology.

A Structure-Based Approach to Understanding Somatostatin Receptor-4 Agonism (sst4)

Christina Hayes, Daniel Ansbro, Maria Kontoyianni, 2012, J. Chem. Inf. Model..

NNC 26-9100 increases Aβ1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells

J. Schober, A. Crider, Karin E. Sandoval, 2021, PloS one.

Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.

M. Khan, M. A. Khan, A. Crider, 1994, Journal of pharmaceutical sciences.

Somatostatin Receptor-4 Agonists as Candidates for Treatment of Alzheimer’s Disease

A. Crider, Karin E. Sandoval, M. Kontoyianni, 2014 .

Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice

David S. Umbaugh, A. Crider, Karin E. Sandoval, 2019, Neurochemical Research.

Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ42 oligomers via a metalloproteinase-dependent mechanism

W. Banks, J. Morley, S. Farr, 2013, Brain Research.

Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.

S. Farr, A. Crider, Karin E. Sandoval, 2021, RSC medicinal chemistry.

Somatostatin sst4 ligands: chemistry and pharmacology.

A. Crider, K. Witt, 2007, Mini reviews in medicinal chemistry.

The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain.

P. J. Larsen, A. Fink-Jensen, M. Scheideler, 1997, European journal of pharmacology.

Anticonvulsant activity of the nipecotic acid ester, (±)-m-nitrophenyl-3-piperidinecarboxylate

K. Seibert, A. Crider, C. Hinko, 1984, Neuropharmacology.

Synthesis of 3-(3-hydroxyphenyl)pyrrolidine dopamine D3 receptor ligands with extended functionality for probing the secondary binding pocket.

A. Crider, W. Neumann, Shakiba Eslamimehr, 2018, Bioorganic & medicinal chemistry letters.

Synthesis and Evaluation of Morpholinoalkyl Ester Prodrugs of Indomethacin and Naproxen

M. Khan, A. Crider, M. Narurkar, 1993, Pharmaceutical Research.

Synthesis and evaluation of cis-1-methyl-3-n-propyl-2,3,3a,4,5,9b-hexahydro-1H-benz[e]indoles for in vitro dopamine D1 and D2 receptor binding affinity

A. Crider, P. H. Andersen, Debasis Ghosh, 1995 .

Synthesis and Evaluation of cis-1-Methyl-3-n-propyl-2,3,3a,4,5,9b- hexahydro-1H-benz(e)indoles for in vitro Dopamine D1 and D2 Receptor Binding Affinity.

A. Crider, P. H. Andersen, Debasis Ghosh, 1996 .

3-Phenylpyrrolidines: synthesis and evaluation of the in vitro binding affinity at D1 and D2 receptors

A. Crider, P. H. Andersen, Debasis Ghosh, 1992 .

Synthesis and dopaminergic activity of trans-4-methyl-3-phenylpyrrolidines

S. Fahn, A. Crider, K. Tschappat, 1987 .

Synthesis and Dopaminergic Activity of trans-4-Methyl-3-phenylpyrrolidines.

S. Fahn, A. Crider, K. Tschappat, 1988 .

Novel Somatostatin Receptor-4 Agonist SM-I-26 Mitigates Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia

A. Crider, Karin E. Sandoval, W. Neumann, 2021, Neurochemical Research.

Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores.

J. Stables, A. Crider, B. Ho, 2001, European journal of medicinal chemistry.

Novel Somatostatin Receptor-4 Agonist SM-I-26 Mitigates Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia

A. Crider, Karin E. Sandoval, W. Neumann, 2021, Neurochemical Research.

Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor.

A. Crider, M. Kontoyianni, E. Kuzhikandathil, 2015, Pharmacological research.

Esters of nipecotic and isonipecotic acids as potential anticonvulsants.

J. Wood, A. Crider, C. Hinko, 1982, Journal of pharmaceutical sciences.